Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
暂无分享，去创建一个
S. Loibl | N. Harbeck | V. Nekljudova | Marcus Schmidt | G. von Minckwitz | M. Andersson | T. Čufer | F. D. de Jongh | R. Stein | N. Maass | C. Mundhenke | C. Zielinski | H. Lück | J. Barinoff | E. Maartense | J. Bischoff | K. Baumann | K. Schwedler